Albaracin, Richard R.
HRN: 26-02-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2024
CEFTRIAXONE 1G (VIAL)
10/15/2024
10/22/2024
IV
2g
OD
UTI, Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes